Last fall, Rules-Based Medicine, of Austin, Texas, left the shelter of its parent company Luminex to provide tests for biochemical markers that use Luminex’s bead-based xMAP technology. The 16-employee spinoff, which is ten percent owned by Luminex, and headed by Luminex founder and former CEO Mark Chandler, started offering testing services in October.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.